2015-001040-11
Proactive treatment with 0.03% tacrolimus cream in children with moderate/severe dermatitis
Astellas Pharma China, Inc.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Atopic Dermatitis
Sponsor & location
- Primary sponsor
- Astellas Pharma China, Inc.
- Funder
- Astellas Pharma China, Inc
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Patients with known allergy to tacrolimus ointment;
ICD-10 classifications
Atopic dermatitisAtopic dermatitis, unspecifiedOther atopic dermatitisAcute atopic conjunctivitisAllergic contact dermatitis
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2015-001040-11
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2015-001040-11 through Pure Global AI's free database. This phase not specified trial is sponsored by Astellas Pharma China, Inc. and is currently status unknown. The study focuses on Atopic Dermatitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.